Kyriakos Mikellis is the appointed Pfizer Country lead for Cyprus and Malta and has 30 years of experience in the pharmaceutical sector. He was elected President of KEFEA for a second term (2022-2024). As its President of a local industrial association, he was involved in the negotiations for the reform of the Cyprus Healthcare System. Mr. Mikellis also leads the Cyprus Medicines Verification Organization, (KOEΦ) responsible for the application of the falsified medicines regulations in Cyprus. He is also a member of the Heath Committee of the American Chamber of commerce in Cyprus (AmCham). Before joining Pfizer in 2010 through the Wyeth acquisition, he had served as Country Manager of Wyeth Pharmaceuticals. Kyriakos Mikellis holds a degree in Biology from the University of Athens.